Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Asrt Stock Analysis Assertio Holdings Inc. Gains 4.30 Percent To Hit 19.88 Price Level 20260401 1 Is FBS Global FBGL stock failing to hold levels At Lows 20260418 GRNQ Greenpro Capital Corp reports Q1 2024 EPS of negative 004 with no public analyst estimates available for the quarter Why Hanover Bancorp HNVR ability to generate cash matters On the Radar 20260507 Axon AXON Stock Smart Money Signals Bullish Sentiment 20260418 Kevin Warshs Potential Federal Reserve Overhaul Targets Wall Streets Market Plumbing EU Industrial Sovereignty at Risk Five Sectors Critically Dependent on China Market Technical Assessment Signals Bullish IntermediateTerm Outlook Amazons Growing Influence in High Fashion Met Gala Controversy Raises Industry Eyebrows Trump Seeks Supreme Court Intervention to Halt TikTok Ban Waymo Temporarily Expands Robotaxi Pause in Five US Cities After Flooded Road Incidents CMBM Q3 2024 Earnings EPS Surpasses Estimates but Revenue Details Omitted AWI Q1 2026 Earnings EPS Falls Short as Revenue Picture Remains Unclear MFIN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction COHU Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Resilient Sentiment KGEI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions MRNA Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Blackrock Limited Duration Income Trust BLW Edges Higher Amid Stable Trading Radian Group Inc RDN Faces Resistance as Shares Dip 184 Testing Key Support Zone OmniAb Inc OABI Shares Edge Higher as Key Support Holds Yunji Inc YJ Slides 774 Amid Selling Pressure Approaches Key Support John Wiley Sons WLY Edges Higher Modest Gains Amid Consolidation Phase Orthofix Medical OFIX Plunges 9 as Stock Tests Key Support Levels ACCESS Newswire Inc ACCS Slides 5 as Selling Pressure Intensifies AN2 Therapeutics ANTX Rallies 5 as Bulls Test Critical Resistance at 540 Medicinova Inc MNOV Edges Higher on Modest Volume Faces Key Resistance at 141 Kalaris Therapeutics KLRS Posts Modest Gain Holding Above Key Support